1,3-Calix[4]arene Crown Ether Conformers
J . Org. Chem., Vol. 64, No. 16, 1999 5883
1
tosylate; mp 116-117 °C (MeCN); H NMR δ 0.97, 0.99, 1.27
(s, 2 H each), 6.93 and 7.01 (ABq, J ) 2.5 Hz, 4 H), 7.05 (dd,
J ) 4.9, 1.2 Hz, 1 H), 7.10 (dd, J ) 3.0, 1.2 Hz, 1 H), and 7.28
(dd, J ) 4.9, 3.0 Hz, 1 H); 13C NMR (TCE, +85 °C) δ 30.6,
30.9 (t, OCH2CH2Th and ArCH2Ar), 31.1, 31.2, 31.3 (×2) (q,
C(CH3)3), 33.4, 33.5, 33.6 (×2) (s, C(CH3)3), 60.7 (q, OCH3), 70.4,
70.9, 71.9, 72.3, 74.4 (t, OCH2CH2O and OCH2CH2Th), 120.8,
124.8 124.85, 124.91, 125.0, 125.1, 128.4 (d, Ar and Th), 132.7,
133.2, 133.7, 134.3 (s, bridgehead-C), 139.1 (s, 3-Th), 144.1,
144.8 (s, Csp2-tBu), 152.2, 153.9, and 154.6 (s, Csp2-O); FAB
(+) MS, m/z 931 (MH+). Anal. Calcd for C59H78O7S: C, 76.09;
H, 8.44; S, 3.44. Found: C, 75.82; H, 8.55; S, 3.51.
(s, ratio 1:1:2, 36 H), 3.26 and 4.34 (AX, J ) 12.8 Hz, 4 H),
3.29 (t, J ) 7.0 Hz, 2 H), 3.31 and 4.19 (AX, J ) 13.1 Hz, 4 H),
4.13 (t, J ) 7.0 Hz, 2 H), 5.04 (s, 2 H), 6.80, 6.85 (s, 2 H each),
7.03 (ABq, J ) 2.4 Hz, 4 H), 7.12 (dd, J ) 4.6, 1.5 Hz, 1 H),
7.19-7.22 (m, 2 H), 7.32-7.43 (m, 3 H), 7.46 (s, 2 H), 7.72 (d,
J ) 7.2 Hz, 2 H); 13C NMR δ 30.8, 31.7, and 31.8 (t, ArCH2Ar
and OCH2CH2Th), 31.03, 31.05, 31.6 (q, C(CH3)3), 33.8, 33.96,
34.0 (s, C(CH3)3), 76.4 (t, OCH2CH2Th), 78.3 (t, OCH2Ph),
122.0, 125.00, 125.04, 125.5, 125.6 (d, Ar and Ph), 127.7 (s,
bridgehead-C), 128.0, 128.1, 128.52, 128.56 (d, Ar, Ph, and Th),
132.7, 132.9 (s, bridgehead-C), 136.8 (s, Ph), 138.2 (s, 3-Th),
141.5, 147.1, 147.3 (s, Csp2-tBu), 149.7, 149.8, and 150.5 (s,
Csp2-O); FAB (+) MS, m/z 849 (MH+). Anal. Calcd for
C57H68O4S: C, 80.61; H, 8.08; S, 3.77. Found: C, 80.46; H, 8.17;
S, 3.82.
5,11,17,23-Tetr a k is(1,1-d im eth yleth yl)-25-p r op oxy-27-
ben zyloxy-26,28-d ih yd r oxy-ca lix[4]a r en e (2c): obtained in
68% yield from 1b and propyl iodide; mp 237-238 °C (MeOH);
1H NMR δ 1.00, (s, 18 H), 1.20 (t, J ) 7.4 Hz, 3 H), 1.27 (s, 18
H), 1.99 (m, 2 H), 3.29 (d, J ) 13.0 Hz, 4 H), 3. 92 (t, J ) 6.3
Hz, 2 H), 4.26, 4.32 (d, J ) 13.0 Hz, 2 H each), 5.05 (s, 2 H),
6.84, 6.85 (s, 2 H each), 7.03 (pseudo-s, 4 H), 7.36-7.45 (m, 3
H), and 7.71-7.74 (m, 4 H); 13C NMR δ 10.9 (q, OCH2CH2CH3),
23.4 (t, OCH2CH2CH3), 31.05, 31.06, 31.7 (q, C(CH3)3), 31.8 (t,
ArCH2Ar), 33.8, 33.9, 34.0 (s, C(CH3)3), 77.9, 78.0 (t, OCH2-
CH2CH3 and OCH2Ph), 125.0, 125.4, 125.6, 127.5, 127.8, 128.4
(d, Ar and Ph), 127.6, 127.7, 132.7, 132.8 (s, bridgehead-C),
137.1 (s, Ph), 141.2, 146.7, 146.9 (s, Csp2-tBu), 149.77, 149.81,
and 150.8 (s, Csp2-O); FAB (+) MS, m/z 781 (MH+). Anal. Calcd
for C54H68O4: C, 83.02; H, 8.78. Found: C, 82.75; H, 8.64.
Syn th esis of 1,3-Br id ged Ca lix[4]a r en e Cr ow n Eth er s
3 a n d 4. Gen er a l P r oced u r e. A mixture of 2 (1.0 mmol) and
Cs2CO3 (3.26 g, 10 mmol) in anhydrous MeCN (80 mL) was
refluxed for 1 h. Then a solution of the appropriate oligoeth-
ylene glycol ditosylate (1.1 equiv.) in anhydrous MeCN (20 mL)
was added dropwise over 2 h under rapid stirring. The mixture
was refluxed for an additional 36-48 h. Progress of the
reaction was monitored by TLC, following the disappearance
of the ditosylate. After evaporation of the solvent, the residue
was partitioned between 1 N HCl and CH2Cl2. The organic
extract was washed with water, dried over MgSO4, and
concentrated. The crude product was separated into the pure
components by column chromatography (SiO2, CH2Cl2-AcOEt
7:1; petroleum ether-AcOEt 10:1 for 3c and 4c) to afford
conformers 3 (fastest moving products) and 4. For 3a and 4a ,
the elution order was inverted.
5,11,17,23-Tetr a k is(1,1-d im eth yleth yl)-25-m eth oxy-27-
[2-(3-th ien yl)eth oxy]â-26,28-cr own -5r-calix[4]ar en e,23 an ti
Con for m er (3a ): 47% yield, mp 261-263 °C (MeCN); 1H NMR
(TCE, +100 °C) δ 1.22, 1.28, 1.46 (s, ratio 2:1:1, 36 H), 2.00,
2.96 (t, J ) 7.2 Hz, 2 H each), 3.33 (s, 3 H), 3.44-3.68 (m, 18
H), 3.89 (pseudo-s, 4 H), 4.22 (d, J ) 13.9 Hz, 2 H), 6.57 (dd,
J ) 3.0, 1.2 Hz, 1 H), 6.68 (dd, J ) 4.9, 1.2 Hz, 1 H), 6.98 and
7.05 (ABq, J ) 2.5 Hz, 4 H), 7.03 (s, 2 H), 7.14 (dd, J ) 4.9,
3.0 Hz, 1 H), and 7.16 (s, 2 H); 13C NMR (TCE, +85 °C) δ 30.0
(t, OCH2CH2Th), 31.2 (×2), 31.4, 31.6 (q, C(CH3)3), 33.5, 33.6,
33.7 (s, C(CH3)3), 33.8 (t, ArCH2Ar), 60.8 (q, OCH3), 69.4 (t,
OCH2CH2Th), 70.4, 70.5, 70.6, 72.2 (t, OCH2CH2O), 119.7,
124.2, 125.0, 125.5, 125.8, 126.4, 128.1 (d, Ar and Th), 132.7,
133.2, 133.6, 134.1 (s, bridgehead-C), 139.1 (s, 3-Th), 144.0,
144.3, 144.4 (s, Csp2-tBu), 154.1, 154.2, and 154.8 (s, Csp2-O);
FAB (+) MS, m/z 931 (MH+). Anal. Calcd for C59H78O7S: C,
76.09; H, 8.44; S, 3.44. Found: C, 76.27; H, 8.58; S, 3.35.
5,11,17,23-Tetr a k is(1,1-d im eth yleth yl)-25-m eth oxy-27-
[2-(3-th ien yl)eth oxy]r-26,28-cr ow n -5r-ca lix[4]a r en e,23 syn
Con for m er (4a ): 31% yield; mp 168-169 °C (MeCN); 1H NMR
(TCE, +100 °C) 1.03, 1.18, 1.24 (s, ratio 1:1:2, 36 H), 3.17 (br
s, 3 H), 3.19 and 4.45 (AX, J ) 12.6 Hz, 4 H), 3.30 (t, J ) 7.9
Hz, 2 H), 3.38 and 4.25 (AX, J ) 12.2 Hz, 4 H), 3.67-3.81 (m,
8 H), 4.00-4.13 (m, 8 H), 4.26 (t, J ) 7.9 Hz, 2 H), 6.72, 6.86
5,11,17,23-Tetr a k is(1,1-d im eth yleth yl)-25-m eth oxy-27-
[2-(3-th ien yl)eth oxy]â-26,28-cr own -6r-calix[4]ar en e,23 an ti
Con for m er (3a a ): 41% yield; mp 311-312 °C (MeCN-CH2-
1
Cl2); H NMR (CDCl3, +22 °C) δ 1.04, 1.35, 1.46 (s, ratio 2:1:
1, 36 H), 3.05 and 4.29 (AX, J ) 12.8 Hz, 4 H), 3.10 (br t, J )
9.0 Hz, 2 H), 3.33 (s, 3 H), 3.44-3.68 (m, 14 H), 3.70 (br s, 4
H), 3.80 (br t, J ) 8.6 Hz, 4 H), 3.95 (br d, J ) 9.3 Hz, 2 H),
3.94 (br t, J ) 9.0 Hz, 2 H), 6.57 and 6.90 (ABq, J ) 2.5 Hz,
4 H), 6.83 (dd, J ) 2.9, 1.2 Hz, 1 H), 6.94 (dd, J ) 4.9, 1.2 Hz,
1 H), 7.06 (s, 2 H), 7.26 (dd, J ) 4.9, 2.9 Hz, 1 H), and 7.27 (s,
1
2 H); H NMR (TCE, +120 °C) δ 1.12, 1.40, 1.52 (s, ratio 2:1:
1, 36 H), 3.04 (br t, J ) 8.3 Hz, 2 H), 3.12 and 4.35 (AX, J )
13.1 Hz, 4 H), 3.41 (s, 3 H), 3.53 (s, 4 H), 3.60-3.82 (m, 16 H),
3.86 (br t, J ) 8.3 Hz, 2 H), 3.96-4.08 (m, 4 H), 6.68 and 6.94
(ABq, J ) 2.5 Hz, 4 H), 6.92-6.96 (m, 2 H), 7.09, (s, 2 H), and
7.26-7.28 (m, 3 H); 13C NMR (CDCl3, +22 °C) δ 31.3 (t,
OCH2CH2Th), 31.4, 31.7 (q, C(CH3)3), 31.8 (t, ArCH2Ar), 32.0
(q, C(CH3)3), 33.7, 34.1 (s, C(CH3)3), 39.1 (t, ArCH2Ar), 61.1
(q, OCH3), 70.6, 70.7, 71.2, 71.5, 71.7, 73.1 (t, OCH2CH2O and
OCH2CH2Th), 120.8, 125.0, 125.4, 125.45, 125.47, 125.50, 128.2
(d, Th and Ar), 131.4, 132.8, 133.1, 135.9 (s, bridgehead-C),
138.3 (s, Th), 143.1, 143.8, 144.6 (s, Csp2-tBu), 154.2, 154.8,
and 156.0 (s, Csp2-O); FAB (+) MS, m/z 975 (MH+). Anal. Calcd
for C61H82O8S: C, 75.11; H, 8.48; S, 3.28. Found: C, 75.44; H,
8.31; S, 3.15.
5,11,17,23-Tetr a k is(1,1-d im eth yleth yl)-25-m eth oxy-27-
[2-(3-th ien yl)eth oxy]r-26,28-cr ow n -6r-ca lix[4]a r en e,23 syn
Con for m er (4a a ): 24% yield; mp 256-257 °C (MeOH-CH2-
1
Cl2); H NMR (CDCl3, -30 °C) δ 0.82, 1.35, 1.37 (s, ratio 2:1:
1, 36 H), 3.16, 3.18 (d, J ) 12.2 Hz, 2 H each), 3.51-3.78 (m,
18 H), 4.00 (t, J ) 9.1 Hz, 4 H), 4.18 (s, 3 H), 4.38-4.42 (m, 2
H), 4.41, 4.49 (d, J ) 12.2 Hz, 2 H each), 6.46 and 6.50 (ABq,
J ) 2.4 Hz, 4 H), 7.15, 7.19 (s, 2 H each), 7.27 (dd, J ) 4.9, 1.2
Hz, 1 H), 7.31 (dd, J ) 4.9, 2.8 Hz, 1 H), and 7.38 (dd, J ) 2.8,
1.2 Hz, 1 H); 1H NMR (TCE, +120 °C) 1.04, 1.26, 1.30 (s, ratio
2:1:1, 36 H), 3.20 and 4.49 (AX, J ) 12.4 Hz, 4 H), 3.22 and
4.48 (AX, J ) 13.1 Hz, 4 H), 3.50 (t, J ) 8.2 Hz, 2 H), 3.65 (s,
4 H), 3.68-3.78 (m, 8 H), 3.84-4.06 (m, 11 H), 4.39 (t, J ) 8.2
Hz, 2 H), 6.68 and 6.73 (ABq, J ) 2.5 Hz, 4 H), 6.98, 7.01 (s,
2 H each), 7.14 (dd, J ) 5.0, 1.2 Hz, 1 H), 7.21 (dd, J ) 3.0,
1.2 Hz, 1 H), and 7.29 (dd, J ) 5.0, 3.0 Hz, 1 H); 13C NMR
(CDCl3, +22 °C) δ 31.2 (q, C(CH3)3), 31.46, 31.50 (t, OCH2CH2-
Th and ArCH2Ar), 31.7 (q, C(CH3)3), 33.6, 34.07, 34.08 (s,
C(CH3)3), 61.9 (q, OCH3), 70.9, 71.0, 71.4, 74.4, 74.7 (t,
OCH2CH2O and OCH2CH2Th), 121.6, 124.3, 124.6, 124.7,
125.0, 125.4, 129.3 (d, Th and Ar), 131.8, 132.9, 135.5, 135.9
(s, bridgehead-C), 139.3 (s, Th), 144.3, 144.6, 144.8 (s, Csp2
-
tBu), 153.0, 154.6, and 156.5 (s, Csp2-O); FAB (+) MS, m/z 975
(MH+). Anal. Calcd for C61H82O8S: C, 75.11; H, 8.48; S, 3.28.
Found: C, 75.27; H, 8.32; S, 3.23.
5,11,17,23-Tet r a k is(1,1-d im et h ylet h yl)-25-b en zyloxy-
27-[2-(3-th ien yl)eth oxy]-26,28-cr ow n -5-ca lix[4]a r en e, 1,3-
Alter n a te Con for m er (3b): 53% yield; mp 252-254 °C
(MeCN); 1H NMR δ 0.94, 1.40, 1.41 (s, ratio 2:1:1, 36 H), 2.44
(dd, J ) 9.3, 7.8 Hz, 2 H), 2.96-3.04 (m, 4 H), 3.37-3.69 (m,
14 H), 3.80 and 3.87 (ABq, J ) 16.7 Hz, 4 H), 3.91 (pseudo-s,
4 H), 4.59 (s, 2 H), 6.68-6.71 (m, 4 H), 6.84 (m, 1 H), 6.86 (dd,
J ) 4.9, 1.3 Hz, 1 H), 6.94 (d, J ) 2.6 Hz, 2 H), 7.03-7.05 (m,
3 H), 7.06, 7.10 (s, 2 H each), and 7.24 (dd, J ) 4.9, 2.9 Hz, 1
H); 13C NMR δ 30.3 (t, OCH2CH2Th), 31.3, 31.9 (q, C(CH3)3),
33.6, 34.04, 34.06 (s, C(CH3)3), 39.2, 39.5 (t, ArCH2Ar), 67.1,
70.3, 70.5, 70.9, 71.1, 73.5 (t, OCH2CH2O, OCH2CH2Th, and
OCH2Ph), 120.1, 125.1, 125.2, 125.4, 125.5, 125.6, 126.0, 126.2,
127.7, 128.1 (d, Th, Ar, and Ph), 132.97, 132.99 133.05, 133.4
(23) Notations R and â were introduced by Shinkai11 to define the
stereochemistry of calix[4]arene atropisomers having mixed substit-
uents at the lower rim.